Bayer (BAYN GY) has received its third approval in China for advanced prostate cancer
Importance
Level 1
#GERMANY#EUROPE#BAYER AG#BAYN.GY#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BAYN#EURO STOXX 50#DAX 40 INDEX